Inhibition of DNMT1 Attenuates Experimental Food Allergy

Linjing Li,Wenjing Pang,Lingzhi Xu,Yuanyi Zhang,Hanqing Zhang,Liming Zhu,Yuyi Li,Huapeng Lin,Lihua Mo,Yu Liu,Lei Wang,Pingchang Yang
DOI: https://doi.org/10.1016/j.molimm.2024.07.009
IF: 4.174
2024-01-01
Molecular Immunology
Abstract:Background The treatment of food allergy (FA) needs improvement. The treatment of immune disorders can be improved by regulating epigenetic marks, which is a promising method. The objective of this research is to alleviate experimental FA by employing an inhibitor of DNA methyltransferase-1 (DNMT1). Methods Ovalbumin was used as the specific antigen to establish a mouse model of FA. Intestinal IL-35+ regulatory B cells (Breg cells) were isolated from FA mice, and characterized using immunological approaches. Results FA mice had a lower frequency of IL-35+ Breg cells, which was inversely correlated with their FA response. The quantity of IL-35 was lower in intestinal Breg cells from FA mice. Hypermethylation status was detected in the Il35 promoter, which was accompanied with high levels of H3K9me3. Enforced expression of DNMT1 hindered the promoter activity of the IL35 gene. Administration of an inhibitor of DNMT1 (RG108) restored the immune regulatory capacity of FA intestinal Bregs, and effectively suppressed the expression of DNMT1, and attenuated experimental FA. Conclusions The elevated quantity of DNMT1 in intestinal Breg cells compromises the expression of IL-35 and affects the immune regulatory functions, which facilitates the development of FA. The immune regulatory functions of intestinal Breg cells are restored and experimental FA is attenuated by inhibiting DNMT1.
What problem does this paper attempt to address?